Imiquimod topical for Basal Cell Carcinoma User Reviews (Page 4)
Brand names: Aldara, Zyclara
Reviews for Imiquimod topical
- Sop...
- Taken for 1 to 6 months
- March 9, 2015
"Got rid of my basal cell carcinoma, no scarring."
- Hop...
- October 20, 2016
Imiquimod topical "The side effects are terrible and caused diarrhea for months! This can be a dangerous drug. I went to doctor after doctor, colonoscopy, etc. I figured it out myself, finally."
Frequently asked questions
- What are the most common skin conditions? (with photos)
- Does duct tape really remove warts?
- Is imiquimod the same as Aldara?
- Does Zyclara work for genital warts?
- KGb...
- July 2, 2015
"Using for a BCC on my chin for 12 weeks. Currently at week 6, and it has increased in size, blistered, and crusted. Side effects include nausea and some flu-like symptoms."
- Anonymous
- Taken for less than 1 month
- December 2, 2015
Imiquimod topical "This is awful, the burning is terrible!"
- Jea...
- Taken for less than 1 month
- November 14, 2019
Imiquimod topical "I have used Aldara for a few days on my BCC, and the results are incredible."
- jam...
- November 19, 2015
"Derm. put me on for a total of 4 weeks, redness, open dry sores on scalp. Week three, three times per week hope it works, MWF off weekends seems to be working."
- Ric...
- Taken for less than 1 month
- November 23, 2021
"My Celtic/Scandinavian genes don't work so well living in the Far East. After multiple surgeries for BCC and skin grafts, this is far easier and far less stressful."
See also:
Learn more about Basal Cell Carcinoma
Care guides
Symptoms and treatments
More about imiquimod topical
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (456)
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anti-infectives
- Breastfeeding
- En español
Patient resources
- Imiquimod topical drug information
- Imiquimod (Advanced Reading)
- Imiquimod Cream (Aldara)
- Imiquimod Cream (Zyclara)
Imiquimod topical "Works very well. Some slight scarring."